Published in Nature · View the paper (DOI)
Researchers have visualized the structure of the MFSD2A transporter protein, which allows omega-3s to enter the brain. The study provides insight into how this protein can be used to design drugs that mimic omega-3s and hijack the system for neurological treatment.
Coverage from 2 institutions